| Anti-Trypanosoma cruzi and anti-leishmanial activity by quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives JC Villalobos-Rocha, L Sánchez-Torres, B Nogueda-Torres, ... Parasitology research 113 (6), 2027-2035, 2014 | 61 | 2014 |
| The effect of relative humidity on tensile strength and water vapor permeability in chitosan, fish gelatin and transglutaminase edible films S Alvarado, G Sandoval, I Palos, S Tellez, Y Aguirre-Loredo, G Velazquez Food Science and Technology 35, 690-695, 2015 | 50 | 2015 |
| Repositioning FDA Drugs as Potential Cruzain Inhibitors from Trypanosoma cruzi: Virtual Screening, In Vitro and In Vivo Studies I Palos, EE Lara-Ramirez, JC Lopez-Cedillo, C Garcia-Perez, M Kashif, ... Molecules 22 (6), 1015, 2017 | 47 | 2017 |
| Thermal degradation of poly (vinyl chloride) synthesized with a titanocene catalyst VH Ponce-Ibarra, R Benavides, G Cadenas-Pliego, I Palos-Pizarro, ... Polymer degradation and stability 91 (3), 499-503, 2006 | 33 | 2006 |
| Ligand-based virtual screening and molecular docking of benzimidazoles as potential inhibitors of triosephosphate isomerase identified new trypanocidal agents LK Vázquez-Jiménez, A Juárez-Saldivar, R Gómez-Escobedo, ... International Journal of Molecular Sciences 23 (17), 10047, 2022 | 26 | 2022 |
| Virtual Screening of FDA-Approved Drugs against Triose Phosphate Isomerase from Entamoeba histolytica and Giardia lamblia Identifies Inhibitors of Their … A Juárez-Saldivar, E Barbosa-Cabrera, EE Lara-Ramírez, ... International Journal of Molecular Sciences 22 (11), 5943, 2021 | 25 | 2021 |
| Recent advances in the development of triose phosphate isomerase inhibitors as antiprotozoal agents LK Vázquez-Jiménez, A Moreno-Herrera, A Juárez-Saldivar, ... Current Medicinal Chemistry 29 (14), 2504-2529, 2022 | 21 | 2022 |
| Anti-Mycobacterium tuberculosis Activity of Esters of Quinoxaline 1,4-Di-N-Oxide I Palos, J Luna-Herrera, EE Lara-Ramírez, A Loera-Piedra, ... Molecules 23 (6), 1453, 2018 | 21 | 2018 |
| Old antiprotozoal drugs: are they still viable options for parasitic infections or new options for other diseases? S Cortez-Maya, A Moreno-Herrera, I Palos, G Rivera Current Medicinal Chemistry 27 (32), 5403-5428, 2020 | 16 | 2020 |
| Synthesis, biological evaluation and molecular docking of new benzenesulfonylhydrazone as potential anti-Trypanosoma cruzi agents S Elizondo-Jimenez, A Moreno-Herrera, R Reyes-Olivares, ... Medicinal Chemistry 13 (2), 149-158, 2017 | 16 | 2017 |
| Neuropeptide Y1 and Y5 receptor antagonists as potential anti-obesity drugs: current status A Moreno-Herrera, A García, I Palos, G Rivera Mini reviews in medicinal chemistry 14 (11), 896-919, 2014 | 12 | 2014 |
| Poly (vinyl alcohol) obtained by hydrolysis of poly (vinyl silyl ethers) and poly (vinyl ethers) synthesized with indenyltitanium trichloride I Palos, G Cadenas-Pliego, SY Knjazhanski, EJ Jiménez-Regalado, ... Polymer degradation and stability 90 (2), 264-271, 2005 | 12 | 2005 |
| Esters of quinoxaline 14-Di-N-oxide with cytotoxic activity on tumor cell lines based on NCI-60 panel G Rivera, SSA Shah, D Arrieta-Baez, I Palos, A Mongue, ... Iranian Journal of Pharmaceutical Research: IJPR 16 (3), 953, 2017 | 11 | 2017 |
| Esters of quinoxaline-7-carboxylate-1, 4-di-N-oxide as Trichomonas vaginalis triosephosphate isomerase inhibitors I Palos, R Moo-Puc, JL Vique-Sánchez, CG Benítez-Cardoza, A Monge, ... Acta Pharmaceutica 71 (3), 485-495, 2021 | 10 | 2021 |
| Bibliometric analysis of scientific publications in the field of medicinal chemistry in Latin America, the People’s Republic of China, and India G Rivera, G Puras, I Palos, C Ordaz-Pichardo, V Bocanegra-Garcia Medicinal Chemistry Research 19 (6), 603-616, 2010 | 10 | 2010 |
| Ester of Quinoxaline-7-carboxylate 1, 4-di-N-oxide as Apoptosis Inductors in K-562 Cell Line: An in vitro, QSAR and DFT Study G Rivera, S Andrade-Ochoa, M S Ortega Romero, I Palos, A Monge, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2017 | 9 | 2017 |
| Antitubercular drugs development: recent advances in selected therapeutic targets and rational drug design V Bocanegra-García, A García, JP Palma-Nicolás, I Palos, G Rivera A case study based insight into modern strategies. Intech open, 207-42, 2011 | 9 | 2011 |
| Encapsulation and release characteristics of glibenclamide loaded calcium-alginate beads D Charles-Navarro, V Bocanegra-García, I Palos, G Rivera, ... Quimica nova 33, 1435-1439, 2010 | 8 | 2010 |
| Virtual Screening of Benzimidazole Derivatives as Potential Triose Phosphate Isomerase Inhibitors with Biological Activity against Leishmania mexicana LK Vázquez-Jiménez, A Juárez-Saldivar, MJ Chan-Bacab, ... Pharmaceuticals 16 (3), 390, 2023 | 7 | 2023 |
| Medicinal chemistry in public health: our experience in the design of potential therapeutic molecules G Rivera, I Palos, M Mireles-Martínez, NM Rosas-García, ... Revista mexicana de ciencias farmacéuticas 45 (1), 15-25, 2014 | 6 | 2014 |
Gildardo RiveraCentro de Biotecnologia Genomica, Instituto Politecnico NacionalVerified email at ipn.mx
